Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events

The use of immune checkpoint inhibitors (ICIs) for the treatment of various malignancies is increasing. Immune-related adverse events can occur after ICI administration, with gastrointestinal adverse events constituting a significant proportion of these events. When ICI-related diarrhea/colitis is s...

Full description

Bibliographic Details
Published in:	Clinical Endoscopy
Main Authors:	Min Kyu Kim, Sung Wook Hwang
Format:	Article
Language:	English
Published:	Korean Society of Gastrointestinal Endoscopy 2024-11-01
Subjects:	drug-related side effects and adverse reactions endoscopy, gastrointestinal histology immune checkpoint inhibitors
Online Access:	http://www.e-ce.org/upload/pdf/ce-2024-003.pdf

Similar Items

Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review
by: Sung Wook Hwang, et al.
Published: (2023-10-01)

Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
by: Hamzah Abu-Sbeih, et al.
Published: (2018-09-01)

Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review
by: Elizabeth S Mearns, et al.
Published: (2018-03-01)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system
by: Yue Li, et al.
Published: (2020-04-01)

Clinical Diagnosis and Treatment of Immune-related Adverse Events in Digestive System Related to Immune Checkpoint Inhibitors
by: Yue LI, et al.
Published: (2019-10-01)

Endoscopic Findings of Upper Gastrointestinal Involvement in Primary Vasculitis
by: Eun Jeong Gong, et al.
Published: (2016-07-01)

Immune checkpoint inhibitors⁃related nervous system adverse events
by: WANG Ze⁃yi, et al.
Published: (2022-09-01)

Comparison of hemodynamics and respiratory function between ciprofol-remifentanil and propofol-remifentanil in obese patients undergoing gastrointestinal endoscopic anesthesia: a randomized controlled trial
by: Chunfang Jian, et al.
Published: (2025-10-01)

Baseline profile peripheral Tfh cells predict immune-related adverse events in immune checkpoint inhibitor therapy of gastrointestinal cancer
by: Yifan Wang, et al.
Published: (2025-05-01)

Predictors of positive endoscopic findings in hospitalized patients with occult gastrointestinal bleeding
by: Neil Sengupta, et al.
Published: (2015-12-01)

Upper gastrointestinal endoscopic findings in children at rapareen teaching hospital in Erbil, Iraq
by: Dlair Abdulkhaleq Chalabi
Published: (2020-01-01)

Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
by: Prasanna Duraisamy, et al.
Published: (2023-07-01)

Characterizing immune checkpoint inhibitor-related cutaneous adverse reactions: A comprehensive analysis of FDA adverse event reporting system (FAERS) database
by: Buğra Han Esen, et al.
Published: (2024-07-01)

Sedation-related adverse events in gastrointestinal endoscopy (CH-ESC study): study protocol for a prospective, observational cohort study in a Chinese tertiary hospital
by: Jun Lu, et al.
Published: (2025-09-01)

Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: A Minireview of Current Clinical Guidelines
by: Saralinh Trinh, et al.
Published: (2019-01-01)

Immune checkpoint inhibitor-induced endocrinopathies: a possible indicator of improved survival
by: Mariana Ornelas, et al.
Published: (2023-07-01)

Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
by: Linyang Gan, et al.
Published: (2023-03-01)

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
by: Maria Luisa De Perna, et al.
Published: (2025-08-01)

Cutaneous adverse events due to checkpoint inhibitors – a retrospective analysis at a tertiary referral hospital in Switzerland 2019-2022
by: Clara Furrer-Matcau, et al.
Published: (2024-12-01)

Clinical analysis of 22 cases of cutaneous adverse reactions caused by molecular targeted antitumor agents and immune checkpoint inhibitors
by: Kui MU, et al.
Published: (2023-12-01)

Pancreatic adverse events in patients treated with immune checkpoint inhibitors
by: Caroline Hana, et al.
Published: (2023-03-01)

Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
by: Jiaxin ZHOU, et al.
Published: (2019-10-01)

Neurologic adverse events of cancer immunotherapy
by: Marcelo Houat de Brito
Published: (2022-08-01)

Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review
by: Paulo Nunes Filho, et al.
Published: (2023-03-01)

Preclinical Assessment of Tissue Effects by Gastrointestinal Endoscope Tip Temperature
by: Luise Jäger, MSc, et al.
Published: (2023-01-01)

Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract
by: Michael Dougan
Published: (2017-11-01)

Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors
by: Yifan Zhang, et al.
Published: (2023-03-01)

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events
by: Peng Song, et al.
Published: (2020-08-01)

Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
by: Hanna Karhapää, et al.
Published: (2022-02-01)

Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
by: Parneet K. Cheema, et al.
Published: (2024-10-01)

Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events
by: Junling ZHUANG, et al.
Published: (2019-10-01)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
by: Junling Zhuang, et al.
Published: (2020-03-01)

The assessment of rheumatologic immune-related adverse events with immune checkpoint inhibitors
by: Emre Tekgöz, et al.
Published: (2022-03-01)

Advances in Predictive Research of Immune Checkpoint Inhibitors-related  Adverse Events
by: Jing ZHANG, et al.
Published: (2023-10-01)

Clinical characteristic analysis of immune checkpoint inhibitor-related pituitary adverse events
by: Yufan ZHENG, et al.
Published: (2025-08-01)

Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
by: A. Martens, et al.
Published: (2023-02-01)

Endoscopic Features of Gastrointestinal Amyloidosis: A Proposed Endoscopic Classification
by: Joo Hye Song, et al.
Published: (2025-07-01)

Endoscopic vacuum therapy for gastrointestinal transmural defects: a literature review
by: Tan Minh Le, et al.
Published: (2025-03-01)

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
by: Lingli Luo, et al.
Published: (2023-04-01)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
by: Xiaoyan Si, et al.
Published: (2020-02-01)